Latest Articles
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times
Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore
Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri
Published: June 17, 2026, 7:01 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Cision News
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Cision News
Published: June 17, 2026, 7 a.m.
Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment - EMJ
Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment EMJ
Published: June 16, 2026, 9:15 a.m.
Lotus Endometriosis Institute Announces Resources For Diagnosis & Patient Advice - USA Today
Lotus Endometriosis Institute Announces Resources For Diagnosis & Patient Advice USA Today
Published: June 13, 2026, 7:32 p.m.
‘Significant’ treatment to be discontinued: A patient’s perspective - Royal Australian College of General Practitioners (RACGP)
‘Significant’ treatment to be discontinued: A patient’s perspective Royal Australian College of General Practitioners (RACGP)
Published: June 12, 2026, 4:51 a.m.
Less Pain, Fewer Opioids for Hypermobility Patients Who Use Cannabis - NORML
Less Pain, Fewer Opioids for Hypermobility Patients Who Use Cannabis NORML
Published: June 11, 2026, 3:44 p.m.
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years MSN
Published: June 8, 2026, 8:37 p.m.
RUBY Trial Suggests Some Patients With Advanced Endometrial Cancer May Be Living Cancer-Free for Years - SurvivorNet
RUBY Trial Suggests Some Patients With Advanced Endometrial Cancer May Be Living Cancer-Free for Years SurvivorNet
Published: June 8, 2026, 8:12 p.m.
Link copied to clipboard!